AGP Picks
View all

Tel Aviv Free Press
Provided by AGP

Tel Aviv Free Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tel Aviv Free Press.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 18, 2026

Duke Robotics Corp. Announces Closing of $9.2 Million Underwritten Public Offering and Uplisting to NASDAQ
May 18, 2026

Duke Robotics Corp. Announces Closing of $9.2 Million Underwritten Public Offering and Uplisting to NASDAQ

Indeterminate GlobeNewswire
Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
May 18, 2026

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development

Indeterminate GlobeNewswire
BOS Expands RFID Division to Israel’s Defense Sector
May 18, 2026

BOS Expands RFID Division to Israel’s Defense Sector

Indeterminate GlobeNewswire
Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution
May 18, 2026

Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution

Indeterminate GlobeNewswire
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 18, 2026

Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact
May 18, 2026

Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact

Indeterminate GlobeNewswire
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire
BrainsWay Announces Minority-Stake Investment in Hopemark Health
May 18, 2026

BrainsWay Announces Minority-Stake Investment in Hopemark Health

Indeterminate GlobeNewswire
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation
May 18, 2026

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Indeterminate GlobeNewswire
Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market
May 18, 2026

Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market

Indeterminate GlobeNewswire
Allot to Present at TD Cowen’s 54th Annual Technology, Media & Telecom Conference on May 27-28, 2026
May 18, 2026

Allot to Present at TD Cowen’s 54th Annual Technology, Media & Telecom Conference on May 27-28, 2026

Indeterminate GlobeNewswire

Share this page:

Sign up for:

Tel Aviv Free Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.